Embedded Files
PharmOA: Supporting Community Pharmacies To Care For People With OA
PharmOA: Supporting Community Pharmacies To Care For People With OA
UPDATED - 04 August 2022
Osteoarthritis is a common condition that causes pain, difficulties in undertaking normal activities and decreases quality of life. The problems caused by osteoarthritis can have negative impact on society. For example, people may stop working or undertaking caring activities, and there is a direct impact on the NHS. We hope to minimise these negative outcomes through improving care. Instead of the general practice, people could seek help from their local pharmacy to manage their osteoarthritis. This could include advice about how to manage pain and other symptoms with exercise, weight loss, medication, and other aids. This would make access to high quality, consistent, effective care more readily available and convenient. It will benefit practices by freeing-up appointments to tackle other issues.
To provide appropriate support for community pharmacies to care for people with osteoarthritis, we aim to first:
understand patients, community pharmacy teams (CPs) and other health care professionals’ experiences and views about extended CP roles in delivering osteoarthritis care.
co-design and refine existing tools to support extended CP roles to deliver osteoarthritis care (PharmOA tools)
To achieve these aims, the team will:
Undertake surveys and interviews with: patients aged 45 years and over with joint pain and osteoarthritis; community pharmacy teams; and other health professionals. This will enable us to identify ways that community pharmacies could better support people with osteoarthritis, making sure it is acceptable to all groups
Complete stakeholder co-design and engagement workshops to refine existing tools to support extended CP roles to deliver osteoarthritis care (PharmOA tools), informed by the survey and interview findings
HI History
HI History
EMIS - Search uploaded 4th August 2022
SystmOne - Search uploaded 4th August 2022
If other RRDNs would like access to these files, please email wm.rrdn@nihr.ac.uk
Disclaimer:
Please note the resources provided are designed to assist with the identification of potentially suitable patients and to appropriately code these patient if required.
These resources have been developed based on the criteria provided by the relevant study team and whilst every effort has been made to make them universally implementable they rely on read codes and the data stored in the individual practice's clinical system. These resources are intended to assist with identification but should be used in conjunction with clinical oversight and a clear understanding of the study parameters.
While we endeavour to keep the information, tools and resources provided up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the tools provided for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of the tools provided.
Page updated
Report abuse